Summary:
To determine the possible role that leuko trienes ( L Ts) may play in the regulation of cerebral blood flow, the responses of cerebral arterioles to L Ts and 12hydroxyeicosatetraenoic acid (12-HETE) were studied in vivo in rabbits equipped with a cranial window for direct observation of the microcirculation, Topical application ofLT C 4 , LT D 4 , or 12-HETE (1.6 x 10-9-3,1 x 10-6 M) neither constricted nor dilated the pial arteries, L TB 4 pro duced only a 5% vasoconstriction at 3,0 x 10-6 M. How ever, bradykinin induced dose-dependent arteriolar va-Leukotrienes (LTs) are formed by lipoxygenase enzyme metabolism of arachidonic acid and are thought to be important mediators of allergic and other inflammatory reactions (Samuels son et al., 1980) . LTB4 has potent chemotactic activity (Ford Hutchinson et aI., 1980) . LTC4 and its derivatives LTD4 and LTE4 constitute the slow-reacting sub stances of anaphylaxis and cause bronchiolar smooth muscle contraction and increased vascular permeability (Murphy et aI., 1979; Dahlen et aI., 1980; Samuels son et al., 1980; Woodward et al., 1983) . Some LTs have potent vasoconstrictor ac tivity in peripheral vasculatures including the cor onary (Ezra et aI., 1983; Roth and Lefer, 1983) , renal (Rosenthal and Pace-Asciak, 1983) , and mes enteric (Feigen, 1983 ) vascular beds. However, the effect of LTs on the cerebral circulation is equiv ocal. Ta gari et al. (1983) showed that intracarotid injection of LTD4 (1-15 nmol/kg) constricted the in ternal carotid and other large arteries in rats and sodilation and histamine and 5-hydroxytryptamine in duced dose-dependent arteriolar vasoconstriction. Although some L Ts have potent vasoconstrictor activity in peripheral tissues and 5-lipoxygenase products have been hypothesized to be mediators of vasospasm after subarachnoid hemorrhage, L TB 4 , L TC4, L TD 4 , and 12-HETE apparently are unable to induce significant con striction of the cerebral arterioles in the anesthetized rabbit. Key Words: Arachidonic acid cascade-Brain microcirculation-Leukotrienes. that LTD4 (2 x 10-9-2 x 10-7 M) caused sustained contraction of isolated human intracranial arteries.
However, Holst et al. (1982) reported that L TC4 and LTD4 had no effect on isolated, superfused human cerebral artery strips. Recently, Ellis et al. (1984) revealed that lip oxygenase products, although mainly 12-hydroxyeicosatetraenoic acid (12-HETE), can be synthesized from endogenous and exogenous arachidonic acid in mouse brain tissue slices, suggesting that lipoxygenase products may play an important role in the brain. Moreover, based on the report that there is a close time rela tionship between the increase in 5-HETE, a 5-li poxygenase product, in CSF and the development of cerebral vasospasm in patients with subarach noid hemorrhage, Sasaki et al. (1982) have pro posed that 5-lipoxygenase products cause vaso spasm after subarachnoid hemorrhage.
To test if lipoxygenase products can modulate ce rebral blood flow, we examined the effect of LTs and 12-HETE on in vivo pial arterioles. Rabbits were chosen as the experimental animal since their cerebral circulation is similar to that of primates (Abboud, 1981) . In addition, topical application of the test agents using a closed cranial window allows maintenance of a normal local environment and en-abIes one to measure changes in diameter that are independent of widespread or systemic effects that may be produced by arterial or venous infusions of vasoactive substances.
METHODS
A total of 23 male New Zealand white rabbits weighing 2.9-4.2 kg were studied under anesthesia produced by sodium pentobarbital (25 mg/kg, i.v.), urethane (560 mg/ kg, s.c.), and a-chloralose (38 mg/kg, s.c.). The sodium pentobarbital was given only once, at the beginning of the experiment to quicken the onset of anesthesia, since the other anesthetic agents were given subcutaneously. After completion of the tracheotomy, each animal was artifi cially ventilated with room air. The end-expiratory CO2 of the animal was continuously monitored with an Anarad Inc. (Santa Barbara, CA, U.S.A.) infrared CO2 analyzer and was maintained at a level of � 34 mm Hg throughout each experiment by adjusting the respirator rate and volume. Arterial blood pressure was measured with a Stat ham P23Db pressure transducer connected to a cannula inserted into the left femoral artery. Arterial blood sam ples were periodically analyzed with an Instrumentation Laboratory (Lexington, MA, U.S.A.) blood pH/blood gas analyzer to ensure a normal range of Pa02, Pac02, and blood pH.
Pial arterioles ranging in diameter between 32 and 82 f.l,m were visualized using a previously described cranial window technique (Lavasseur et aI., 1975) . The cranial window was implanted on the midline just caudal to the suture connecting the frontal and parietal bones. Two to four vessels were studied in each animal using a Vickers image-splitting device according to the method described by Baez (1966) . The cranial window was equipped with three openings. Two openings were used as an inlet and outlet for filling the space under the cranial window with test solutions. The third opening was connected to a Stat ham pressure transducer for continuous measurement of intracranial pressure. The intracranial pressure outlet of the window was connected to plastic tubing, the open end of which was placed at a fixed level to give a constant intracranial pressure throughout the experiment (5.6 ± 0.1 mm Hg, mean ± SE). The space under the window and the plastic tubing connected to it were filled with artificial CSF (Lavasseur et aI., 1975) . This fluid was equilibrated with gas containing 6.6% 02' 5.9% CO2, and 87.5% nitrogen, which gives gas tensions and a pH in the normal range for CSF (pH 7.399 ± 0.012, Pc02 38.6 ± 1.0 mm Hg, P02 76.9 ± 2.5 mm Hg). Before pharmaco logical experiments were conducted, normal pial arteri olar reactivity was ensured by ventilating with 5% CO2 in air and observing pial vasodilation. Blood gases were returned to normal before the experiments with vasoac tive agents. Drug doses were applied in a cumulative manner. Diameters reached a steady-state response be tween 2 and 5 min, and the responses reported are the maximum response between 2 and 5 min after adminis tration of the test substance. The experiments were con ducted using groups of three to eight animals. The data were analyzed using Student's t test for paired observa tions, thereby comparing each drug-induced response with its vehicle control response.
To ensure that the L TC4 we used was intact and bio logically active, we tested its effect on isometric tension in the isolated guinea pig ileum. Guinea pigs were killed by cervical dislocation. The ileum was removed and then cut and suspended in Krebs-Ringer bicarbonate buffer (pH 7.4) that was gassed with 95% 0zl5% CO2, We also wished to show that our dihydroxylated L T, L TB4, was structurally intact. Since L TB 4 is not active on the guinea pig ileum, we tested its integrity by gas chromatography/ mass spectrometry. An aliquot of L TB4 was first meth ylated with diazomethane, and then the trimethylsilyl ether was formed with bis-trimethylsilyl trifluoroacet amide (BSTFA), as we have done previously (Ellis et aI., 1982) . The derivatized LTB4 was analyzed on a Hewlett Packard capillary gas chromatograph/5970B mass selec tive detector. The column was 12 m long, with 0.2-mm internal diameter, and coated with a 0.33-f.I,m thickness of cross-linked methyl silicone. The gas chromatograph was run isothermally at 235°C. Data were collected and analyzed using a Hewlett-Packard 9816 computer.
Histamine and 5-hydroxytryptamine (5-HT) were pur chased from Sigma Chemical Co. (St. Louis, MO, U.S.A.) and prepared daily in artificial CSF. LTB4, LTC4, and LTD4 were the kind gift of Dr. J. Rokach at Merck Frosst Canada, Inc. (Pointe Claire-Dorval, Quebec, Canada). LTC4 and LTD4 were dissolved and stored in distilled water. L TB4 was dissolved and stored in meth anol. We biosynthesized 12-HETE from tritiated arachi donic acid and unlabeled arachidonic acid using the li poxygenase enzyme in human platelets. One unit of human platelets was obtained from the blood bank and washed as outlined by . The washed platelets were resuspended in 100 ml Krebs-Henselheit buffer without calcium and were incubated for I h at 37°C with 20 mg of the sodium salt of arachidonic acid plus 2 f.l,Ci of [3Hlarachidonic acid (New England Nuclear, Boston, MA, U.S.A.). The incubation was performed in a metabolic shaker gassed with 95% 0zl5% CO2, This ratio of platelets to substrate provides a large excess of substrate for the 12-lipoxygenase enzyme. After the I-h incubation, 30 ml of acetone was added to the platelets, the pH was adjusted to 3.0 with 88% formic acid, the incubate was extracted two times with 100 ml of ethyl acetate, and the extract was evaporated under vacuum. The residue was then dissolved in HPLC solvent and fil tered with a 0.45-f.I,m Millipore filter. The 12-HETE was then purified by HPLC. The biosynthesized 12-HETE was dissolved in methanol/water/acetic acid (690:310:0.1, vol/vol/vol) and injected into a C IS HPLC column, and the column was eluted with this solvent run at 2 ml/min. Using this solvent, 12-HETE eluted from the column at fraction nos. 28-29. The fractions containing 12-HETE were pooled; an aliquot was evaporated, derivatized, and its 12-HETE structure confirmed by gas chromatography/ mass spectrometry (Hamberg and Samuels son, 1974) . The 12-HETE was stored in methanol until used. All LTs and 12-HETE were stored at -70°C. The maximum methanol concentration used in testing the vasoactivity of 12-HETE and LTB4 was 0.1 f.l,l/ml CSF. Although this concentration of methanol had no effect on pial arteriolar diameter (1.4 ± 1.0%), the arteriolar responses to 12-HETE and LTB4 were compared with the appropriate methanol-containing vehicle. All test agents were added to artificial CSF at 37°C that had been gassed as described above. for L TC4, 9 arterioles in three rabbits for L TD4, and 11 arteries in three rabbits for 12-HETE. "Significantly different from vehicle control at p < 0.01.
RESULTS
The mean (± SE) arterial blood pressure in all an imals was 80. 6 ± 1. 7 mm Hg and therefore similar to that reported for unanesthetized rabbits (Aylward et al. , 1983) . Arterial blood gases and pH were as follows: P a02 90. 1 ± 1. 6 mm Hg, P aco2 31. 4 ± 0. 6 mm Hg, and pH 7. 485 ± 0. 011. As shown in Fig.   1 , topical application of LTC4, LTD4, or 12-HETE neither constricted nor dilated the pial arterioles in doses of 1. 6 x 10-9-3. 1 x 10-6 M. LTB4 produced a weak but statistically significant vasoconstriction. Histamine (3. 3 x 10-4 M) was applied topically at the end of these lipoxygenase metabolite studies in order to ensure the responsiveness of the arterioles at the end of the experiment. Histamine always in duced marked vasoconstriction (31. 4 ± 3.9%). To test the possibility that topically applied LTs or 12-HETE might not be able to reach and bind with the appropriate pial arteriolar receptor because of bar riers such as the pia mater (Hervonen et al. , 1981) , we also infused these agents into the internal ca-J Cereb Blood Flow Metabol, Vol. 5, No.4, 1985 rotid artery at doses of 1-100 ng/kg/min. However, all of the LTs and 12-HETE showed no effect on pial arteriolar diameter (data not shown).
Since the LTs were inactive in the cerebral cir culation, regardless of the route of administration, we tested to ensure that they were structurally in tact or biologically active in systems known to re spond to LTs. Also, Dahlen (1983) and Dahlen et al. (1983) have shown that lung tissue is tachyphy lactic to L Ts and that cumulative doses may not produce the same degree of biological activity as a single administration. We therefore tested the ac tivity of one dose of LTC4 (1. 6 iJ-M) on the pial vessels of four different animals, thus avoiding a cumulative dose-response study. Also, on the same day, and from the same stock vial of LTC4, aliquots were taken to examine biological activity using the guinea pig ileum. We found that individual doses of LTC4 (1. 6 iJ-M) had no effect on rabbit pial arteri oles, yet induced an easily measurable contraction of the guinea pig ileum at a concentration of 8 nM (Fig. 2) . In addition, we found that our LTB4 was structurally intact since it produced the same mass spectrum as originally published by Borgeat and Samuelsson (1979) (Fig. 3) . Characteristic frag Contrary to the results with LTs, topical appli cation of other vasoactive agents showed a marked effect on rabbit pial arteriolar diameter (Fig. 4) . 
DISCUSSION
Previous experiments have shown that arachi donic acid or its cyclooxygenase products are va soactive when topically applied to the in situ cere bral vasculature (Ellis et aI. , 1979; Wei et aI. , 1980) . However, whereas L Ts are also formed from ara- Values are mean ± SE of 21 arterioles in eight rabbits for bradykinin, 17 arterioles in seven rabbits for 5-HT, and 14 arterioles in six rabbits for histamine. Significantly different from vehicle control at *p < 0.05, **p < 0.01, and ***p < 0.001.
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FIG. 3. The mass spectrum of leuko triene B4 (L TB4)' The same stock of LTB4 that produced only weak vasocC'n striction of pial arterioles produced the above characteristic mass spectrum, as originally reported by Borgeat and Sam uelsson (1979) .
chidonic acid and the existence of their synthesizing enzymes in the brain seems probable (Koide et aI. , 1982; Ellis et aI. , 1984) , little is known about their action on the cerebral arteries. The present data
show that topical application of major 5-lipoxy genase products made from arachidonic acid, LTB4, LTC4, and LTD4, and of a 12-lipoxygenase product, 12-HETE, have little or no effect on the diameter of in vivo pial arterioles of the rabbit.
These data are consistent with the results of Holst et aI. (1982) showing no effect of LTC4 and LTD4 in isolated, superfused human cerebral arteries.
However, Ta gari et aI. (1983) reported that LTD4 (2 x 10-9 to 2 X 10-7 M) caused sustained contrac tions of isolated human intracranial arteries, al though the effect was not dose dependent. The reason for the above discrepancies is uncertain but may include factors such as drug stability (Roth and Lefer, 1983) of the test animal. If P aco2 is high or blood pressure is low, autoregulatory vasodilation of the cerebral vasculature will occur. This vasodilation may render the arteries more reactive to vasoconstrictor chemical agents. Sasaki et al. (1982) has recently reported that the appearance of 5-HETE in CSF of patients with sub arachnoid hemorrhage correlates with the severity of cerebral vasospasm, suggesting an important role for 5-lipoxygenase products in the pathogenesis of vasospasm. However, our results do not support LTC4 or LTD4 as causative substances of vaso spasm. We cannot rule out, however, that 5-HETE compounds may be vasoactive.
Although the pharmacology of the rabbit cerebral circulation has been studied previously, it has not been characterized as extensively as it has been in other species, such as the cat. Because of this rel ative lack of study of the rabbit and our negative results with the lipoxygenase metabolites, we thought it important to further characterize the re sponse of the rabbit pial arterioles to other vaso active agents using our particular experimental preparation. Our finding that bradykinin induces a dose-dependent vasodilation and that histamine in duces a dose-dependent vasoconstriction shows that the reactivity of our preparation is intact.
Bradykinin has previously been demonstrated to produce concentration-dependent relaxation of in vitro intracranial vessels from a wide variety of spe cies including human (Toda, 1977; Wahl et aI., 1983) , rabbit (Toda, 1977; , and cat Whalley and Wahl, 1983) .
Bradykinin induces in vivo cerebral vasodilation in cats Whalley and Wahl, 1983; Kontos et aI., 1984) and goats (Hoffman et aI., 1983) . The receptor-mediating bradykinin dilation of the superficial pial arteries of the cat is of the B2 type, which is present in a wide variety of vascular preparations (Whalley and Wahl, 1983 (1977)]. This contractile ef fect is thought to be due to the release of catechol amines from the arteries via stimulation of HI-re ceptors (Edvinsson et aI., 1983) . Histamine-induced dilation has also been reported in isolated cerebral arteries given a tonic contraction and in in vivo cat cerebral vessels (Raper et al., 1972) . Histamine-in duced dilation appears to be mediated mainly by specific Hrreceptors since specific Hrantagonists shift the dilator dose response to histamine to the right in a parallel manner (Edvinsson and Mac Kenzie, 1977; Wahl and Kuschinsky, 1979; Ed vinsson et al., 1983) . The above observations sug-J Cereb Blood Flow Metabol, Vol. 5, No. 4, 1985 gest that histamine can mediate both vasoconstric tion and vasodilation. Nevertheless, we have not observed histamine-induced vasodilation in in vivo rabbit pial arterioles, perhaps suggesting an absence of H2-receptors in the rabbit.
The release of 5-HT is thought to occur after stroke, brain trauma, cold injury lesions, and ische mia, and it has been hypothesized that it may re duce cerebral blood flow. Our results support a va soconstrictor role for 5-HT, but the relatively weak response, even at higher concentrations, argues against an important role for 5-HT in vivo. The same opinion was expressed by Martins et al. (1978) who showed that topical application of 5-HT on pial arterioles of monkeys had no effect. Interestingly, it has been shown in other species that perivascular application of 5-HT to pial vessels affects tone, de pending on the resting diameter of the vessel. For example, large conducting vessels constrict in re sponse to 5-HT, whereas small resistance arterioles dilate (Edvinsson and MacKenzie, 1977; Harper and MacKenzie, 1977) .
In conclusion, our data show that with topical application using a closed cranial window chamber, rabbit pial arterioles are responsive to bradykinin, histamine, and 5-HT. Our results do not, however, support a role for LTs and 12-HETE in the modu lation of arteriolar tone in the normal cerebral cir culation. Yet, whether lipoxygenase compounds may affect cerebrovascular permeability or whether reactivity to lipoxygenase compounds may change following brain injury remains an attractive possi bility.
